Research shows that at age 20, the average person has about 200 ng/mL of GHK in their plasma
This is based on strong clinical trial evidence they are effective
COPPER PEPTIDE GHK-CU MARKET, BY END-USER (USD MILLION) TABLE 19 CANADA COPPER PEPTIDE GHK-CU MARKET, BY PRODUCT TYPE (USD MILLION) TABLE 20 CANADA COPPER PEPTIDE GHK-CU MARKET, BY APPLICATION (USD MILLION) TABLE 21 CANADA COPPER PEPTIDE GHK-CU MARKET, BY FORM (USD MILLION) TABLE 22 CANADA COPPER PEPTIDE GHK-CU MARKET, BY DISTRIBUTION CHANNEL (USD MILLION) TABLE 23 CANADA COPPER PEPTIDE GHK-CU MARKET, BY END-USER (USD MILLION) TABLE 24 MEXICO COPPER PEPTIDE GHK-CU MARKET, BY PRODUCT TYPE (USD MILLION) TABLE 25 MEXICO COPPER PEPTIDE GHK-CU MARKET, BY APPLICATION (USD MILLION) TABLE 26 MEXICO COPPER PEPTIDE GHK-CU MARKET, BY FORM (USD MILLION) TABLE 27 MEXICO COPPER PEPTIDE GHK-CU MARKET, BY DISTRIBUTION CHANNEL (USD MILLION) TABLE 28 MEXICO COPPER PEPTIDE GHK-CU MARKET, BY END-USER (USD MILLION) TABLE 29 EUROPE COPPER PEPTIDE GHK-CU MARKET, BY COUNTRY (USD MILLION) TABLE 30 EUROPE COPPER PEPTIDE GHK-CU MARKET, BY PRODUCT TYPE (USD MILLION) TABLE 31 EUROPE COPPER PEPTIDE GHK-CU MARKET, BY APPLICATION (USD MILLION) TABLE 32 EUROPE COPPER PEPTIDE GHK-CU MARKET, BY FORM (USD MILLION) TABLE 33 EUROPE COPPER PEPTIDE GHK-CU MARKET, BY DISTRIBUTION CHANNEL (USD MILLION) TABLE 34 EUROPE COPPER PEPTIDE GHK-CU MARKET, BY END-USER (USD MILLION) TABLE 35 GERMANY COPPER PEPTIDE GHK-CU MARKET, BY PRODUCT TYPE (USD MILLION) TABLE 36 GERMANY COPPER PEPTIDE GHK-CU MARKET, BY APPLICATION (USD MILLION) TABLE 37 GERMANY COPPER PEPTIDE GHK-CU MARKET, BY FORM (USD MILLION) TABLE 38 GERMANY COPPER PEPTIDE GHK-CU MARKET, BY DISTRIBUTION CHANNEL (USD MILLION) TABLE 39 GERMANY COPPER PEPTIDE GHK-CU MARKET, BY END-USER (USD MILLION) TABLE 40 U.K
It depends on formulation and protocol
